92 results
424B3
RGBP
Regen BioPharma Inc
20 Nov 23
Prospectus supplement
9:38am
credit equal to 50% of clinical investigation expenses as well as exemptions from certain fees.
The Company believes that this application … States federal tax credit equal to 50% of clinical investigation expenses as well as exemptions from certain fees.
The Company believes
424B3
RGBP
Regen BioPharma Inc
2 Oct 23
Prospectus supplement
1:42pm
% of clinical investigation expenses as well as exemptions from certain fees.
The Company believes that this application of HemaXellerate qualifies for Orphan
8-K
EX-10.1
4cb7byth ob0
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.4
1ez3 7m1vd
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.2
b03yvomov23qr6o
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.3
u4f6ug1pzqmb
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
424B3
2qkbmj 338dqzn2p
15 May 23
Prospectus supplement
10:25am